Skip to content

MBT Sepsityper

by Bruker Daltonik GmbH

510(k) K193419

MBT Sepsityper is a medical device (FDA Class II; FDA product code QNJ, Mass Spectrometry, Microorganism Identification, Blood Culture) made by Bruker Daltonik GmbH, cleared under FDA 510(k) K193419 on 27 Dec 2020, active as of 9 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 9 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 9 Oct 2026.

Regulatory status

as of registry sync 9 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK193419 Date27 Dec 2020ClearedStatusActive

Official records

From the FDA record

Received by the FDA
9 Dec 2019
FDA decision
27 Dec 2020 (Substantially Equivalent)
FDA review time
384 days from receipt to decision
Public document
510(k) statement on file with the FDA

From the FDA 510(k) record K193419 (openFDA), as read on 9 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
QNJ
Device class
Class II
Regulation
21 CFR Part 866.3378
Advisory committee
Microbiology
FDA decision
SESE Substantially Equivalent

Other devices from Bruker Daltonik GmbH

See all devices from Bruker Daltonik GmbH →